Application 021337
- Type
- NDA
- Sponsor
- MERCK SHARP DOHME
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | INVANZ | ERTAPENEM SODIUM | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | EQ 1GM BASE/VIAL | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme LLC | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-3843 | INVANZ | ertapenem sodium | Merck Sharp & Dohme Corp. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
| 42023-221 | ERTAPENEM | ertapenem sodium | Par Pharmaceutical Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 70564 | SUPPL | 2022-03-21 |
| 70555 | SUPPL | 2022-03-18 |
| 65754 | SUPPL | 2020-12-28 |
| 65714 | SUPPL | 2020-12-23 |
| 60172 | SUPPL | 2019-10-01 |
| 60089 | SUPPL | 2019-09-23 |
| 56939 | SUPPL | 2018-12-21 |
| 56895 | SUPPL | 2018-12-20 |
| 55524 | SUPPL | 2018-09-19 |
| 55480 | SUPPL | 2018-09-14 |
| 49809 | SUPPL | 2017-09-20 |
| 49727 | SUPPL | 2017-09-13 |
| 15216 | SUPPL | 2014-10-02 |
| 5081 | SUPPL | 2014-10-02 |
| 42107 | SUPPL | 2014-01-16 |
| 36689 | SUPPL | 2013-07-30 |
| 27515 | SUPPL | 2013-07-26 |
| 15215 | SUPPL | 2012-03-07 |
| 5080 | SUPPL | 2012-03-05 |
| 15214 | SUPPL | 2012-02-22 |
| 15211 | SUPPL | 2011-07-25 |
| 5078 | SUPPL | 2011-07-25 |
| 15213 | SUPPL | 2010-05-28 |
| 27514 | SUPPL | 2010-05-27 |
| 5077 | SUPPL | 2010-01-25 |
| 36688 | SUPPL | 2009-12-15 |
| 5079 | SUPPL | 2009-11-10 |
| 15212 | SUPPL | 2009-10-14 |
| 36687 | SUPPL | 2008-03-27 |
| 5076 | SUPPL | 2008-03-26 |
| 5075 | SUPPL | 2007-11-19 |
| 5074 | SUPPL | 2006-08-14 |
| 36686 | SUPPL | 2006-08-11 |
| 36685 | SUPPL | 2005-10-19 |
| 27513 | SUPPL | 2005-10-19 |
| 36684 | SUPPL | 2005-05-20 |
| 5073 | SUPPL | 2005-05-20 |
| 27512 | SUPPL | 2005-01-26 |
| 27511 | SUPPL | 2004-09-10 |
| 5072 | SUPPL | 2004-05-26 |
| 27510 | SUPPL | 2004-05-04 |
| 36683 | ORIG | 2001-11-09 |
| 21608 | ORIG | 2001-11-09 |
| 5071 | ORIG | 2001-11-09 |
| 51850 | ORIG | 1900-01-01 |
| 51849 | ORIG | 1900-01-01 |
| 51848 | ORIG | 1900-01-01 |
| 51847 | ORIG | 1900-01-01 |